INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.25
arrow_downward
-2.34%(-0.030) 1D
$1.21
arrow_downward
-3.20% (-0.040)bedtimeAfter hours
Closed: Sep 11, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.30
High
$1.31
Low
$1.23
Mkt. cap
129.25M
Avg. vol.
5.73M
Volume
2.39M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.63
Shares outstanding
103.40M
No. of employees
112
Open
$1.30
High
$1.31
Low
$1.23
Mkt. cap
129.25M
Avg. vol.
5.73M
Volume
2.39M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.63
Shares outstanding
103.40M
No. of employees
112
News stories
From web sources and news partners
Pluang
·
8 hours ago
Inovio's lead DNA medicine INO-3107 targets res...
Yahoo Finance
·
12 hours ago
Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms
Investing.com
·
13 hours ago
Inovio at H.C. Wainwright conference: FDA review and launch loom
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc